Literature DB >> 20202962

Risk factors for isoniazid hepatotoxicity in children with latent TB and TB: difference from adults.

Ilker Devrim, Ozgür Olukman, Demet Can, Ceyhun Dizdarer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20202962     DOI: 10.1378/chest.09-2120

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  6 in total

1.  Revised Antituberculosis Drug Doses and Hepatotoxicity in HIV Negative Children.

Authors:  C K Indumathi; Aruna Sethuraman; Saurav Jain; Savita Krishnamurthy
Journal:  Indian J Pediatr       Date:  2018-12-04       Impact factor: 1.967

2.  Evaluation of Treatment Indications, Tuberculin Skin Test, and Bacillus Calmette-Guerin Vaccination Scars in the Cases of Latent Tuberculosis Infection Treatment.

Authors:  Beyhan Çakar
Journal:  Turk Thorac J       Date:  2017-09-27

3.  Isoniazid toxicity in a 5-year-old boy.

Authors:  Michelle Science; Shinya Ito; Ian Kitai
Journal:  CMAJ       Date:  2013-05-13       Impact factor: 8.262

4.  Closing the policy-practice gap in the management of child contacts of tuberculosis cases in developing countries.

Authors:  Philip C Hill; Merrin E Rutherford; Rick Audas; Reinout van Crevel; Stephen M Graham
Journal:  PLoS Med       Date:  2011-10-11       Impact factor: 11.069

5.  Hepatotoxicity Due to Antituberculosis Therapy among Paediatric Patients Seen at the University of Ilorin Teaching Hospital, North Central Nigeria.

Authors:  Gobir Aishatu; Ibraheem Rasheedah; Johnson Wahab; Muhammed Sheni; Oladele Damilola; Ojuola Adeniyi
Journal:  Ethiop J Health Sci       Date:  2017-03

6.  A Long-term Co-perfused Disseminated Tuberculosis-3D Liver Hollow Fiber Model for Both Drug Efficacy and Hepatotoxicity in Babies.

Authors:  Shashikant Srivastava; Jotam G Pasipanodya; Geetha Ramachandran; Devyani Deshpande; Stephen Shuford; Howland E Crosswell; Kayle N Cirrincione; Carleton M Sherman; Soumya Swaminathan; Tawanda Gumbo
Journal:  EBioMedicine       Date:  2016-02-27       Impact factor: 8.143

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.